Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 873

1.

[Intraductal Papillary Mucinous Carcinoma with Penetration in the Colon and Retrograde Infection-A Case Report].

Kurata T, Asakawa T, Fujimori D, Tsuneda A, Kadoya N.

Gan To Kagaku Ryoho. 2019 Dec;46(13):2545-2547. Japanese.

PMID:
32156993
2.

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

Gadgeel S, Rodríguez-Abreu D, Speranza G, Esteban E, Felip E, Dómine M, Hui R, Hochmair MJ, Clingan P, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Garon EB, Novello S, Rubio-Viqueira B, Boyer M, Kurata T, Gray JE, Yang J, Bas T, Pietanza MC, Garassino MC.

J Clin Oncol. 2020 Mar 9:JCO1903136. doi: 10.1200/JCO.19.03136. [Epub ahead of print]

PMID:
32150489
3.

Safety and tolerability of pembrolizumab or placebo plus pemetrexed and platinum as first-line therapy in Japanese patients (PTS) with metastatic non-squamous non-small cell lung cancer (NSCLC) enrolled in the phase III KEYNOTE-189 study.

Horinouchi H, Nogami N, Saka H, Nishio M, Tokito T, Takahashi T, Kasahara K, Hattori Y, Ichihara E, Adachi N, Sawada T, Shimamoto T, Noguchi K, Pietanza MC, Kurata T.

Ann Oncol. 2019 Apr;30 Suppl 2:ii56-ii57. doi: 10.1093/annonc/mdz063.049. No abstract available.

4.

Osimertinib as first-line (1L) treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC): Final efficacy and safety results from two phase I expansion cohorts.

Yang JC, Ramalingam SS, Lee CK, Kurata T, Kim DW, John T, Nogami N, Ohe Y, Rukazenkov Y, Murphy M, Jänne PA.

Ann Oncol. 2019 Apr;30 Suppl 2:ii48. doi: 10.1093/annonc/mdz063.020. No abstract available.

5.

Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study).

Shimizu J, Masago K, Saito H, Nishino K, Kurata T, Itoh Y, Yoshimura Y, Yabuki Y, Dosaka-Akita H.

Ther Adv Med Oncol. 2020 Feb 22;12:1758835920904522. doi: 10.1177/1758835920904522. eCollection 2020.

6.

Human Immune Responses Elicited by an Intranasal Inactivated H5 Influenza Vaccine.

Ainai A, van Riet E, Ito R, Ikeda K, Senchi K, Suzuki T, Tamura SI, Asanuma H, Odagiri T, Tashiro M, Kurata T, Multihartina P, Setiawaty V, Andriana Pangesti KN, Hasegawa H.

Microbiol Immunol. 2020 Jan 20. doi: 10.1111/1348-0421.12775. [Epub ahead of print]

PMID:
31957054
7.

Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study.

Niho S, Yoshida T, Akimoto T, Sakamaki K, Ono A, Seto T, Nishio M, Yamamoto N, Hida T, Okamoto H, Kurata T, Satouchi M, Goto K, Yamanaka T, Ohe Y.

Lung Cancer. 2020 Mar;141:64-71. doi: 10.1016/j.lungcan.2020.01.008. Epub 2020 Jan 10.

PMID:
31955002
8.

Comparative analysis of graft-versus-host disease prophylaxis with tacrolimus in combination with methylprednisolone or methotrexate after umbilical cord blood transplantation.

Shigemura T, Sakashita K, Okura E, Morita D, Komori K, Kurata T, Hirabayashi K, Saito S, Tanaka M, Yanagisawa R, Nakazawa Y.

Int J Hematol. 2020 Jan 18. doi: 10.1007/s12185-020-02826-9. [Epub ahead of print]

PMID:
31953722
9.

Delayed methotrexate clearance and acute kidney injury after high-dose methotrexate chemotherapy concurrent with dasatinib in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report.

Morota H, Saito S, Uchida E, Okura E, Matsuoka D, Hidaka Y, Natsume T, Watanabe T, Shigemura T, Morita D, Tanaka M, Kurata T, Sakashita K, Nakazawa Y.

Pediatr Blood Cancer. 2020 Apr;67(4):e28173. doi: 10.1002/pbc.28173. Epub 2020 Jan 11. No abstract available.

PMID:
31925916
10.

Prophylactic piperacillin administration in pediatric patients with solid tumors following different intensities of chemotherapy.

Saito S, Yanagisawa R, Minami K, Uchida E, Watanabe T, Komori K, Kurata T, Nakamura T, Sakashita K.

Pediatr Int. 2020 Feb;62(2):158-168. doi: 10.1111/ped.14103.

PMID:
31846519
11.

A measles outbreak from an index case with immunologically confirmed secondary vaccine failure.

Kurata T, Kanbayashi D, Egawa K, Kinoshita M, Yoshida H, Miyazono M, Motomura K.

Vaccine. 2020 Feb 5;38(6):1467-1475. doi: 10.1016/j.vaccine.2019.11.075. Epub 2019 Dec 9.

PMID:
31831219
12.

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.

Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, Zhou C, Reungwetwattana T, Cheng Y, Chewaskulyong B, Shah R, Cobo M, Lee KH, Cheema P, Tiseo M, John T, Lin MC, Imamura F, Kurata T, Todd A, Hodge R, Saggese M, Rukazenkov Y, Soria JC; FLAURA Investigators.

N Engl J Med. 2020 Jan 2;382(1):41-50. doi: 10.1056/NEJMoa1913662. Epub 2019 Nov 21.

PMID:
31751012
13.

Support for fungal infection treatment mediated by pharmacist-led antifungal stewardship activities.

Samura M, Hirose N, Kurata T, Ishii J, Nagumo F, Takada K, Koshioka S, Uchida M, Yamamoto S, Inoue J, Enoki Y, Taguchi K, Ishida A, Sekine H, Kunika N, Kunishima H, Matsumoto K.

J Infect Chemother. 2020 Mar;26(3):272-279. doi: 10.1016/j.jiac.2019.09.016. Epub 2019 Nov 12.

PMID:
31732440
14.

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC.

Gray JE, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, Cho BC, Planchard D, Paz-Ares L, Faivre-Finn C, Vansteenkiste JF, Spigel DR, Wadsworth C, Taboada M, Dennis PA, Özgüroğlu M, Antonia SJ.

J Thorac Oncol. 2020 Feb;15(2):288-293. doi: 10.1016/j.jtho.2019.10.002. Epub 2019 Oct 14.

15.

NHE5 regulates growth factor signaling, integrin trafficking, and degradation in glioma cells.

Kurata T, Rajendran V, Fan S, Ohta T, Numata M, Fushida S.

Clin Exp Metastasis. 2019 Dec;36(6):527-538. doi: 10.1007/s10585-019-10001-6. Epub 2019 Oct 8.

16.

Nationwide Molecular Epidemiology of Measles Virus in Japan Between 2008 and 2017.

Seki F, Miyoshi M, Ikeda T, Nishijima H, Saikusa M, Itamochi M, Minagawa H, Kurata T, Ootomo R, Kajiwara J, Kato T, Komase K, Tanaka-Taya K, Sunagawa T, Oishi K, Okabe N, Kimura H, Suga S, Kozawa K, Otsuki N, Mori Y, Shirabe K, Takeda M; Measles Virus Surveillance Group of Japan; Technical Support Team for Measles Control in Japan.

Front Microbiol. 2019 Jul 4;10:1470. doi: 10.3389/fmicb.2019.01470. eCollection 2019.

17.

Concurrent, successful management of bipolar I disorder with comorbid alcohol dependence via aripiprazole long-acting injection: A case report.

Kurata T, Hashimoto T, Suzuki H.

Neuropsychopharmacol Rep. 2019 Sep;39(3):238-240. doi: 10.1002/npr2.12072. Epub 2019 Jul 20.

18.

Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.

Shigemura T, Yanagisawa R, Komori K, Morita D, Kurata T, Tanaka M, Sakashita K, Nakazawa Y.

Transfusion. 2019 Oct;59(10):3065-3070. doi: 10.1111/trf.15456. Epub 2019 Jul 19.

PMID:
31322734
19.

Physcomitrella STEMIN transcription factor induces stem cell formation with epigenetic reprogramming.

Ishikawa M, Morishita M, Higuchi Y, Ichikawa S, Ishikawa T, Nishiyama T, Kabeya Y, Hiwatashi Y, Kurata T, Kubo M, Shigenobu S, Tamada Y, Sato Y, Hasebe M.

Nat Plants. 2019 Jul;5(7):681-690. doi: 10.1038/s41477-019-0464-2. Epub 2019 Jul 8.

PMID:
31285563
20.

Essential role of PTPN11 mutation in enhanced haematopoietic differentiation potential of induced pluripotent stem cells of juvenile myelomonocytic leukaemia.

Shigemura T, Matsuda K, Kurata T, Sakashita K, Okuno Y, Muramatsu H, Yue F, Ebihara Y, Tsuji K, Sasaki K, Nakahata T, Nakazawa Y, Koike K.

Br J Haematol. 2019 Oct;187(2):163-173. doi: 10.1111/bjh.16060. Epub 2019 Jun 20.

PMID:
31222725
21.

Proton Beam Therapy for Adolescent Primary Central Nervous System Lymphoma With Residual Tumor After Intensive Chemotherapy: A Case Report.

Komori K, Saito S, Araya M, Morita D, Kurata T, Hirabayashi K, Tanaka M, Koiwai K, Tauchi K, Masaki H, Nakazawa Y.

Pract Radiat Oncol. 2019 Sep - Oct;9(5):333-337. doi: 10.1016/j.prro.2019.05.005. Epub 2019 May 22. No abstract available.

PMID:
31128305
22.

A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer.

Shimojo M, Kasahara Y, Inoue M, Tsunoda SI, Shudo Y, Kurata T, Obika S.

Sci Rep. 2019 May 20;9(1):7618. doi: 10.1038/s41598-019-43100-1.

23.

SQUAMOSA promoter-binding protein-like 7 mediates copper deficiency response in the presence of high nitrogen in Arabidopsis thaliana.

Mermod M, Takusagawa M, Kurata T, Kamiya T, Fujiwara T, Shikanai T.

Plant Cell Rep. 2019 Jul;38(7):835-846. doi: 10.1007/s00299-019-02422-0. Epub 2019 May 15.

PMID:
31093688
24.

Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA.

Otsubo K, Sakai K, Takeshita M, Harada D, Azuma K, Ota K, Akamatsu H, Goto K, Horiike A, Kurata T, Nakagaki N, Nosaki K, Iwama E, Nakanishi Y, Nishio K, Okamoto I.

Oncologist. 2019 Aug;24(8):1022-1026. doi: 10.1634/theoncologist.2019-0101. Epub 2019 Apr 25.

25.

Long-term cardiovascular prognosis after rotational atherectomy in hemodialysis patients: Data from the J2T multicenter registry.

Jujo K, Otsuki H, Tanaka K, Fukushima N, Okai I, Nakashima M, Dohi T, Okazaki S, Okabe R, Nagura F, Nara Y, Kawashima H, Kyono H, Arashi H, Yamaguchi J, Tamura H, Kurata T, Miyauchi K, Kozuma K, Daida H, Hagiwara N.

Int J Cardiol. 2019 Jun 15;285:14-20. doi: 10.1016/j.ijcard.2019.03.022. Epub 2019 Mar 14.

PMID:
30904279
26.

Reduction of Postoperative Pain by Addition of Intravenous Acetaminophen after Total Hip Arthroplasty: A Retrospective Cohort Study.

Fukumori N, Sonohata M, Kitajima M, Kawano S, Kurata T, Sakanishi Y, Sugioka T, Mawatari M.

Acta Med Okayama. 2019 Feb;73(1):7-14. doi: 10.18926/AMO/56453.

27.

Crystal structure of benzyl 2-naphthyl ether, a sensitiser for thermal paper.

Kikuchi T, Gontani S, Miyanaga K, Kurata T, Akatani Y, Matsumoto S.

Acta Crystallogr E Crystallogr Commun. 2019 Jan 18;75(Pt 2):242-245. doi: 10.1107/S2056989019000690. eCollection 2019 Feb 1.

28.

Off-Site Indoor Localization Competitions Based on Measured Data in a Warehouse.

Ichikari R, Kaji K, Shimomura R, Kourogi M, Okuma T, Kurata T.

Sensors (Basel). 2019 Feb 13;19(4). pii: E763. doi: 10.3390/s19040763.

29.

[A Case of Type 4 Ascending Colon Cancer Showing Early Postoperative Lymphangitis Carcinomatosa].

Katano K, Kurata T, Hagino S, Shoji Y, Sasaki S, Terada I, Yoshikawa A, Kitagawa H, Fujimura T.

Gan To Kagaku Ryoho. 2019 Jan;46(1):139-141. Japanese.

PMID:
30765667
30.

Ovarian function after allogeneic hematopoietic stem cell transplantation in children and young adults given 8-Gy total body irradiation-based reduced-toxicity myeloablative conditioning.

Komori K, Hirabayashi K, Morita D, Hara Y, Kurata T, Saito S, Tanaka M, Yanagisawa R, Sakashita K, Koike K, Nakazawa Y.

Pediatr Transplant. 2019 May;23(3):e13372. doi: 10.1111/petr.13372. Epub 2019 Feb 3.

PMID:
30714283
31.

[A Case of Type 4 Gastric Cancer with Esophageal Invasion That Responded to Neoadjuvant Chemotherapy Containing S-1 and Oxaliplatin followed by Surgery].

Hagino S, Fujimura T, Kurata T, Shoji Y, Sasaki S, Terada I, Yoshikawa A, Kitagawa H, Izumi R, Saito K.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2327-2329. Japanese.

PMID:
30692453
32.

Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.

Niki M, Nakaya A, Kurata T, Nakahama K, Yoshioka H, Kaneda T, Kibata K, Ogata M, Nomura S.

Mol Clin Oncol. 2019 Feb;10(2):267-269. doi: 10.3892/mco.2018.1777. Epub 2018 Nov 27.

33.

BELL1-like homeobox genes regulate inflorescence architecture and meristem maintenance in rice.

Ikeda T, Tanaka W, Toriba T, Suzuki C, Maeno A, Tsuda K, Shiroishi T, Kurata T, Sakamoto T, Murai M, Matsusaka H, Kumamaru T, Hirano HY.

Plant J. 2019 May;98(3):465-478. doi: 10.1111/tpj.14230. Epub 2019 Mar 5.

PMID:
30657229
34.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17.

PMID:
30653423
35.

Subunit Composition of Ribosome in the yqgF Mutant Is Deficient in pre-16S rRNA Processing of Escherichia coli.

Kurata T, Nakanishi S, Hashimoto M, Taoka M, Isobe T, Kato JI.

J Mol Microbiol Biotechnol. 2018;28(4):179-182. doi: 10.1159/000494494. Epub 2018 Dec 19.

PMID:
30566952
36.

Clinical value of enzyme immunoassay that detects rubella-specific immunoglobulin M immediately after disease onset.

Kurata T, Uchino K, Hotta C, Ogura A, Miyoshi T, Ogawa T, Kanbayashi D, Tanaka T, Yumisashi T, Komano J.

Microbiol Immunol. 2019 Jan;63(1):32-35. doi: 10.1111/1348-0421.12664.

PMID:
30549103
37.

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.

Ohe Y, Imamura F, Nogami N, Okamoto I, Kurata T, Kato T, Sugawara S, Ramalingam SS, Uchida H, Hodge R, Vowler SL, Walding A, Nakagawa K.

Jpn J Clin Oncol. 2019 Jan 1;49(1):29-36. doi: 10.1093/jjco/hyy179.

38.

Comparative study of programmed cell death ligand-1 immunohistochemistry assays using 22C3 and 28-8 antibodies for non-small cell lung cancer: Analysis of 420 surgical specimens from Japanese patients.

Saito T, Tsuta K, Ishida M, Ryota H, Takeyasu Y, Fukumoto KJ, Matsui H, Taniguchi Y, Yanagimoto H, Kurata T, Murakawa T.

Lung Cancer. 2018 Nov;125:230-237. doi: 10.1016/j.lungcan.2018.10.005. Epub 2018 Oct 6.

PMID:
30429026
39.

Two-wavelength oximetry of tissue microcirculation based on sidestream dark-field imaging.

Hashimoto R, Kurata T, Sekine M, Nakano K, Ohnishi T, Haneishi H.

J Biomed Opt. 2018 Oct;24(3):1-8. doi: 10.1117/1.JBO.24.3.031013.

40.

Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing.

Iwama E, Sakai K, Azuma K, Harada D, Nosaki K, Hotta K, Nishio M, Kurata T, Fukuhara T, Akamatsu H, Goto K, Shimose T, Kishimoto J, Nakanishi Y, Nishio K, Okamoto I.

Cancer Sci. 2018 Dec;109(12):3921-3933. doi: 10.1111/cas.13820. Epub 2018 Nov 13.

41.

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators.

N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.

PMID:
30280658
42.

Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset.

Cho BC, Chewaskulyong B, Lee KH, Dechaphunkul A, Sriuranpong V, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cheng Y, Cho EK, Voon PJ, Lee JS, Mann H, Saggese M, Reungwetwattana T, Ramalingam SS, Ohe Y.

J Thorac Oncol. 2019 Jan;14(1):99-106. doi: 10.1016/j.jtho.2018.09.004. Epub 2018 Sep 18.

PMID:
30240852
43.

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer.

Niki M, Nakaya A, Kurata T, Yoshioka H, Kaneda T, Kibata K, Ogata M, Nomura S.

Oncotarget. 2018 Aug 17;9(64):32298-32304. doi: 10.18632/oncotarget.25949. eCollection 2018 Aug 17.

44.

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil.

Kurata T, Fushida S, Kinoshita J, Oyama K, Yamaguchi T, Okazaki M, Miyashita T, Tajima H, Ninomiya I, Ohta T.

Cancer Manag Res. 2018 Aug 15;10:2729-2742. doi: 10.2147/CMAR.S167846. eCollection 2018.

45.

Rubella Virus Genotype 1E in Travelers Returning to Japan from Indonesia, 2017.

Kanbayashi D, Kurata T, Nishino Y, Orii F, Takii Y, Kinoshita M, Ohara T, Motomura K, Yumisashi T.

Emerg Infect Dis. 2018 Sep;24(9):1763-1765. doi: 10.3201/eid2409.180621.

46.

Panobinostat inhibits the proliferation of CD34+ CD38- cells under stimulation of hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.

Kurata T, Matsuda K, Hirabayashi K, Shigemura T, Sakashita K, Nakahata T, Koike K.

Pediatr Blood Cancer. 2018 Nov;65(11):e27261. doi: 10.1002/pbc.27261. Epub 2018 Jul 16.

PMID:
30014555
47.

An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumors.

Furuse J, Kurata T, Okano N, Fujisaka Y, Naruge D, Shimizu T, Kitamura H, Iwasa T, Nagashima F, Nakagawa K.

Cancer Chemother Pharmacol. 2018 Sep;82(3):511-519. doi: 10.1007/s00280-018-3618-4. Epub 2018 Jul 10.

48.

A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

Kogure Y, Saka H, Takiguchi Y, Atagi S, Kurata T, Ebi N, Inoue A, Kubota K, Takenoyama M, Seto T, Kada A, Yamanaka T, Ando M, Yamamoto N, Gemma A, Ichinose Y.

Clin Lung Cancer. 2018 Sep;19(5):e711-e715. doi: 10.1016/j.cllc.2018.05.005. Epub 2018 May 19.

PMID:
29861395
49.

Myelodysplastic syndrome in an infant with constitutional pure duplication 1q41-qter.

Morokawa H, Kamiya M, Wakui K, Kobayashi M, Kurata T, Matsuda K, Kawamura R, Kanno H, Fukushima Y, Nakazawa Y, Kosho T.

Hum Genome Var. 2018 May 21;5:6. doi: 10.1038/s41439-018-0008-8. eCollection 2018.

50.

Constitutive BiP protein accumulation in Arabidopsis mutants defective in a gene encoding chloroplast-resident stearoyl-acyl carrier protein desaturase.

Iwata Y, Iida T, Matsunami T, Yamada Y, Mishiba KI, Ogawa T, Kurata T, Koizumi N.

Genes Cells. 2018 Jun;23(6):456-465. doi: 10.1111/gtc.12585. Epub 2018 Apr 24.

Supplemental Content

Loading ...
Support Center